Related references
Note: Only part of the references are listed.miR-27b-3p inhibits estrogen secretion of goose granulosa cells by targeting CYP1B1 through the AMPK signaling pathway
Shenqiang Hu et al.
POULTRY SCIENCE (2023)
Cisplatin nephrotoxicity: new insights and therapeutic implications
Chengyuan Tang et al.
NATURE REVIEWS NEPHROLOGY (2023)
Extracellular vesicles derived from patients with antibody-mediated rejection induce tubular senescence and endothelial to mesenchymal transition in renal cells
Rossana Franzin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
CYP1B1-catalyzed 4-OHE2 promotes the castration resistance of prostate cancer stem cells by estrogen receptor α-mediated IL6 activation
Qimei Lin et al.
CELL COMMUNICATION AND SIGNALING (2022)
Extracellular vesicles in kidney transplantation: a state-of-the-art review
James Ashcroft et al.
KIDNEY INTERNATIONAL (2022)
The Icarus Flight of Perinatal Stem and Renal Progenitor Cells Within Immune System
Angela Picerno et al.
FRONTIERS IN IMMUNOLOGY (2022)
CYP1B1: A Novel Molecular Biomarker Predicts Molecular Subtype, Tumor Microenvironment, and Immune Response in 33 Cancers
Benchao Yuan et al.
CANCERS (2022)
The Long Non-coding RNA HOTAIR Controls the Self-renewal, Cell Senescence, and Secretion of Anti-aging Protein α-Klotho in Human Adult Renal Progenitor Cells
Angela Picerno et al.
STEM CELLS (2022)
Knockdown of LINC00511 decreased cisplatin resistance in non-small cell lung cancer by elevating miR-625 level to suppress the expression of leucine rich repeat containing eight volume-regulated anion channel subunit E
Benkun Liu et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2022)
α-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: Structure activity relationship
Peng Chen et al.
BIOORGANIC CHEMISTRY (2021)
EMT-cancer cells-derived exosomal miR-27b-3p promotes circulating tumour cells-mediated metastasis by modulating vascular permeability in colorectal cancer
Rongzhang Dou et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
Kristen Renee McSweeney et al.
CANCERS (2021)
miR-27b-3p a Negative Regulator of DSB-DNA Repair
Ricardo I. Peraza-Vega et al.
GENES (2021)
Acute kidney injury
John A. Kellum et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Adult stem cells and regenerative medicine-a symposium report
Jennifer Cable et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
Adult kidney stem/progenitor cells contribute to regeneration through the secretion of trophic factors
Kenji Tsuji et al.
STEM CELL RESEARCH (2020)
Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine
Lei Yin et al.
CELLS (2020)
Urinary Extracellular Vesicles as Biomarkers of Kidney Disease: From Diagnostics to Therapeutics
In O. Sun et al.
DIAGNOSTICS (2020)
Long Noncoding RNA MIR210HG Promotes the Warburg Effect and Tumor Growth by Enhancing HIF-1α Translation in Triple-Negative Breast Cancer
Ye Du et al.
FRONTIERS IN ONCOLOGY (2020)
Complement component C5a induces aberrant epigenetic modifications in renal tubular epithelial cells accelerating senescence by Wnt4/βcatenin signaling after ischemia/reperfusion injury
Giuseppe Castellano et al.
AGING-US (2019)
Cisplatin: The first metal based anticancer drug
Sumit Ghosh
BIOORGANIC CHEMISTRY (2019)
Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy
Francesca Conserva et al.
SCIENTIFIC REPORTS (2019)
Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity
Vladislav Volarevic et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism
Simone Romoli et al.
KIDNEY INTERNATIONAL (2018)
Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction
Heta Shah et al.
XENOBIOTICA (2017)
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J. Horley et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Inhibin-A and Decorin Secreted by Human Adult Renal Stem/Progenitor Cells Through the TLR2 Engagement Induce Renal Tubular Cell Regeneration
Fabio Sallustio et al.
SCIENTIFIC REPORTS (2017)
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
Wenjing Mu et al.
CELL RESEARCH (2015)
CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro
Zhuangyan Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Potential Reparative Role of Resident Adult Renal Stem/Progenitor Cells in Acute Kidney Injury
Fabio Sallustio et al.
BIORESEARCH OPEN ACCESS (2015)
Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3
S. A. A. Patel et al.
BRITISH JOURNAL OF CANCER (2014)
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
A Bioartificial Renal Tubule Device Embedding Human Renal Stem/Progenitor Cells
Anna Giovanna Sciancalepore et al.
PLOS ONE (2014)
Urinary CD133+ Extracellular Vesicles Are Decreased in Kidney Transplanted Patients with Slow Graft Function and Vascular Damage
Veronica Dimuccio et al.
PLOS ONE (2014)
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
Abdullah Ozkok et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
Renal progenitors: an evolutionary conserved strategy for kidney regeneration
Paola Romagnani et al.
NATURE REVIEWS NEPHROLOGY (2013)
Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents
Mark A. Perazella
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Mechanisms of Cisplatin Nephrotoxicity
Ronald P. Miller et al.
TOXINS (2010)
CYPIBI expression is induced by docetaxel: effect on cell viability and drug resistance
V. G. Martinez et al.
BRITISH JOURNAL OF CANCER (2008)
Intrinsic epithelial cells repair the kidney after injury
Benjamin D. Humphreys et al.
CELL STEM CELL (2008)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure
Elena Lazzeri et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
MicroRNA regulates the expression of human cytochrome P4501B1
Yuki Tsuchiya et al.
CANCER RESEARCH (2006)
Adult stem cells in the repair of the injured renal tubule
LG Cantley
NATURE CLINICAL PRACTICE NEPHROLOGY (2005)
Role of cysteine S-conjugate β-lyase in the metabolism of cisplatin
L Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Mechanisms of renal cell repair and regeneration after acute renal failure
PA Nony et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme.
B Bournique et al.
DRUG METABOLISM AND DISPOSITION (2002)
Share Paper
